Skip to main content
Premium Trial:

Request an Annual Quote

Ventana to Develop CDx for Merck KGaA

NEW YORK (GenomeWeb) – Ventana Medical Systems today said that it will collaborate with Merck KGaA on a companion diagnostic test for an undisclosed therapeutic target.

According to the firms, Ventana will develop and validate the CDx test for future clinical studies. Further details of the collaboration were not disclosed.

Tucson, Ariz.-based Ventana, which is part of the Roche Group, has several collaborations with biopharmaceutical firms to develop companion diagnostic products. Among its other partners are Bayer, Pfizer, Boehringer Ingelheim, and Takeda's Millennium unit. Last week it announced a deal to develop a companion diagnostic for a MedImmune drug in development for non-small cell lung cancer.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.